Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Sell
25
NSPR Quote, Financials, Valuation and Earnings
Last price:
$1.88
Seasonality move
:
-1.55%
Day range:
$1.84 - $1.90
52-week range:
$1.59 - $3.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.49x
P/B ratio:
1.24x
Volume:
37K
Avg. volume:
157.5K
1-year change:
-37.54%
Market cap:
$79.7M
Revenue:
$7M
EPS (TTM):
-$0.84
Analysts' Opinion
-
Consensus RatingInspireMD, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.50, InspireMD, Inc. has an estimated upside of 139.36% from its current price of $1.88.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $1.88.
Fair Value
-
According to the consensus of 1 analyst, InspireMD, Inc. has 139.36% upside to fair value with a price target of $4.50 per share.
NSPR vs. S&P 500
-
Over the past 5 trading days, InspireMD, Inc. has underperformed the S&P 500 by -5.35% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
InspireMD, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
InspireMD, Inc. has grown year-over-year revenues for 11 quarters straight. In the most recent quarter InspireMD, Inc. reported revenues of $2.5M.
Earnings Growth
-
InspireMD, Inc. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter InspireMD, Inc. reported earnings per share of -$0.17.
Enterprise value:
19.6M
EV / Invested capital:
0.29x
Price / LTM sales:
13.49x
EV / EBIT:
--
EV / Revenue:
2.52x
PEG ratio (5yr expected):
-3.46x
EV / Free cash flow:
-0.58x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.9M
Return On Assets:
-93.23%
Net Income Margin (TTM):
-593.89%
Return On Equity:
-121.49%
Return On Invested Capital:
-113.89%
Operating Margin:
-517.28%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $5.5M | $6.8M | $7.8M | $1.8M | $2.5M | |
| Gross Profit | $1.5M | $1.5M | $1.9M | $414K | $864K | |
| Operating Income | -$20.3M | -$29.9M | -$46.9M | -$8.5M | -$13.1M | |
| EBITDA | -$20M | -$29.7M | -$46.5M | -$8.4M | -$12.9M | |
| Diluted EPS | -$1.52 | -$0.84 | -$0.84 | -$0.16 | -$0.17 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $40.1M | $24.7M | $46.7M | $46.4M | $70.4M | |
| Total Assets | $42.6M | $28.1M | $50M | $50.5M | $78.5M | |
| Current Liabilities | $3.7M | $4M | $4.7M | $7.3M | $10.8M | |
| Total Liabilities | $5.5M | $6.2M | $6.8M | $9.1M | $14.4M | |
| Total Equity | $37.1M | $21.9M | $43.3M | $41.4M | $64.1M | |
| Total Debt | $831K | $1.3M | $1.1M | $682K | $2.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$15.4M | -$19.3M | -$32.5M | -$5.7M | -$8.6M | |
| Cash From Investing | -$12.2M | $4.4M | $22.8M | -$5.9M | $7.6M | |
| Cash From Financing | $37.5M | $16.9M | $57.1M | -$965K | $52.9M | |
| Free Cash Flow | -$15.7M | -$20.6M | -$34.1M | -$6.1M | -$9M | |
NSPR
Sector
Market Cap
$79.7M
$28.5M
Price % of 52-Week High
49.5%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-56.96%
-1.33%
1-Year Price Total Return
-37.54%
-20.32%
Beta (5-Year)
0.696
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.96
200-day SMA
Sell
Level
$2.45
Bollinger Bands (100)
Sell
Level
2.07 - 2.53
Chaikin Money Flow
Sell
Level
-683.5K
20-day SMA
Sell
Level
$1.90
Relative Strength Index (RSI14)
Sell
Level
43.44
ADX Line
Sell
Level
13.77
Williams %R
Neutral
Level
-64.1509
50-day SMA
Sell
Level
$2.15
MACD (12, 26)
Sell
Level
-0.06
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
42.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.0152)
Sell
CA Score
(Annual)
Level (-2.199)
Buy
Beneish M-Score
(Annual)
Level (-3.2394)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (6.1004)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.
Stock Forecast FAQ
In the current month, NSPR has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NSPR average analyst price target in the past 3 months is $4.50.
-
Where Will InspireMD, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that InspireMD, Inc. share price will rise to $4.50 per share over the next 12 months.
-
What Do Analysts Say About InspireMD, Inc.?
Analysts are divided on their view about InspireMD, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that InspireMD, Inc. is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is InspireMD, Inc.'s Price Target?
The price target for InspireMD, Inc. over the next 1-year time period is forecast to be $4.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NSPR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for InspireMD, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of NSPR?
You can purchase shares of InspireMD, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase InspireMD, Inc. shares.
-
What Is The InspireMD, Inc. Share Price Today?
InspireMD, Inc. was last trading at $1.88 per share. This represents the most recent stock quote for InspireMD, Inc.. Yesterday, InspireMD, Inc. closed at $1.88 per share.
-
How To Buy InspireMD, Inc. Stock Online?
In order to purchase InspireMD, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NSPR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NSPR
Sector
P/E ratio
--
23.75x
PEG ratio
-3.46x
-0.01x
P/B ratio
1.24x
1.83x
Price / LTM sales
13.49x
1.60x
Growth Metrics
NSPR
Sector
Revenue growth
39.39%
4.85%
Earnings growth
-6.07%
11.11%
Revenue (5-year growth)
13.5%
6.45%
Earnings forecast
-$0.20
-$0.20
Profitability
NSPR
Sector
Profitability FY 2024
$1.5M
$3.6M
Return on invested capital
-113.89%
-30.98%
Return on assets
-93.23%
-27.62%
Return on equity
-121.49%
-36.69%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Feb
3
Balance Sheet
NSPR
Sector
Total cash
$63.4M
$27.2M
Short term investments
$15.7M
$25.7M
Total assets
$46.8M
$79.7M
Long term debt
$2.4M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
